Windlas Biotech reported a 21% revenue growth in Q1 FY25, with earnings per share increasing to INR 6.47, up 12% year-over-year, driven by strong performance in its CDMO vertical.
AI Assistant
Windlas Biotech Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.